India's pharmaceutical regulator permits modest price increase for essential medicines. The National Pharmaceutical Pricing Authority has allowed manufacturers to raise the Maximum Retail Price of scheduled formulations by 0.64 percent, based on the Wholesale Price Index data for 2025. This adjustment applies to approximately 900 essential medicines listed under the National List of Essential Medicines, including painkillers, antibiotics, and anti-infectives. Notably, manufacturers do not require prior government approval to implement this price increase, as per the Drugs Prices Control Order 2013. The minimal hike reflects the marginal annual change in wholesale prices, balancing manufacturer costs with affordability concerns for consumers dependent on critical medications for basic healthcare needs.
